Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-06-21 @ 3:32 PM
Study NCT ID:
NCT03467958
Status:
TERMINATED
Last Update Posted:
2025-09-17
First Post:
2018-03-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RPC01-3204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None